相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Short-term results of switchback from aflibercept to ranibizumab in neovascular age-related macular degeneration in clinical practice
Raphaelle Despreaux et al.
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2016)
Aflibercept administration in neovascular age-related macular degeneration refractory to previous anti-vascular endothelial growth factor drugs: a critical review and new possible approaches to move forward
Stefano Lazzeri et al.
ANGIOGENESIS (2015)
Pigment Epithelial Detachment Followed by Retinal Cystoid Degeneration Leads to Vision Loss in Treatment of Neovascular Age-Related Macular Degeneration
Ursula Schmidt-Erfurth et al.
OPHTHALMOLOGY (2015)
Efficacy and safety of intravitreal aflibercept injection in wet age-related macular degeneration: outcomes in the Japanese subgroup of the VIEW 2 study
Yuichiro Ogura et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2015)
Tachyphylaxis during ranibizumab treatment of exudative age-related macular degeneration
Sibel Doguizi et al.
INTERNATIONAL JOURNAL OF OPHTHALMOLOGY (2015)
Effect of Switching Therapy to Pegaptanib in Eyes With the Persistent Cases of Exudative Age-Related Macular Degeneration
Chieko Shiragami et al.
MEDICINE (2014)
Aflibercept Therapy for Exudative Age-related Macular Degeneration Resistant to Bevacizumab and Ranibizumab
Benjamin Bakall et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2013)
Aflibercept for exudative AMD with persistent fluid on ranibizumab and/or bevacizumab
Hyung Cho et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2013)
Bevacizumab and ranibizumab tachyphylaxis in the treatment of choroidal neovascularisation
Julie L. Gasperini et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2012)
Tachyphylaxis during treatment of exudative age-related macular degeneration with ranibizumab
Maria Salling Eghoj et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2012)
Intravitreal Aflibercept (VEGF Trap-Eye) in Wet Age-related Macular Degeneration
Jeffrey S. Heier et al.
OPHTHALMOLOGY (2012)
Investigation of the role of neutralizing antibodies against bevacizumab as mediators of tachyphylaxis
Farzin Forooghian et al.
ACTA OPHTHALMOLOGICA (2011)
Do We Need a New Classification for Choroidal Neovascularization in Age-Related Macular Degeneration?
K. Bailey Freund et al.
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2010)
Tachyphylaxis after Repeated Antidepressant Drug Exposure in Patients with Recurrent Major Depressive Disorder
Jay D. Amsterdam et al.
NEUROPSYCHOBIOLOGY (2009)
Nine-Year Incidence and Risk Factors for Age-Related Macular Degeneration in a Defined Japanese Population The Hisayama Study
Miho Yasuda et al.
OPHTHALMOLOGY (2009)
TACHYPHYLAXIS AFTER INTRAVITREAL BEVACIZUMAB FOR EXUDATIVE AGE-RELATED MACULAR DEGENERATION
Farzin Forooghian et al.
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2009)
Is There Tachyphylaxis to Intravitreal Anti-Vascular Endothelial Growth Factor Pharmacotherapy in Age-Related Macular Degeneration?
Shlomit Schaal et al.
OPHTHALMOLOGY (2008)
Quantitative subanalysis of optical coherence tomography after treatment with ranibizumab for neovascular age-related macular degeneration
Pearse A. Keane et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2008)
An optical coherence tomography-guided, variable dosing regimen with intravitreal ranibizumab (lucentis) for neovascular age-related macular degeneration
Anne E. Fung et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2007)
Ranibizumab for neovascular age-related macular degeneration
Philip J. Rosenfeld et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Ten-year incidence and progression of age-related maculopathy
R Klein et al.
OPHTHALMOLOGY (2002)
分享论文
